• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

BioNTech AG. (12/22/16). "Press Release: BioNTech to Present at 35th Annual J.P. Morgan Healthcare Conference 2017". Mainz.

	Region	San Francisco, CA
	Country	United States (USA)
	Organisation	BioNTech AG
	Today	BioNTech SE (Nasdaq: BNTX)
	Group	BioNTech (Group)
	Organisation 2	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 35th Annual Healthcare Conference 2017 San Francisco
	Product 2	mRNA-based vaccine
	Index term	BioNTech–JPMorgan Chase: investor conference, 201701 supply service BioNTech presents at JP Morgan Healthcare Conference 2017
	Index term 2	BioNTech–ICR: public relations, 201712 service existent by ICR Healthcare in US
	Person	Marett, Sean (BioNTech 202012 CBO + CCO 201506 COO before Evotec)
	Person 2	Jehle, Regina (Abivax 201912– Director of Communications before BioNTech 2014– 2019)

BioNTech AG, a fully integrated biotechnology company developing truly individualized cancer immunotherapies, today announced that Sean Marett, COO of BioNTech, will be presenting at 35th Annual J.P. Morgan Healthcare Conference that is being held in San Francisco, CA January 9 – 12, 2017. The presentation is scheduled for Wednesday, January 11th at 9:30 AM Pacific Standard Time. Mr. Marett will provide an overview of the company´s strategy and its most recent substantial progress, including an update of its clinical pipeline, an overview of its strategic collaborations, a summary of its two most recent Nature publications related to its individualized mRNA cancer vaccines and the establishment of a second mRNA production facility at the Company´s headquarters in Germany.

The J.P. Morgan Healthcare Conference brings together corporate leaders, financial sponsors and institutional investors to explore market and sector trends.


For meeting requests or further information, please contact:

General Inqriries
Regina Jehle
BioNTech AG
Phone: +49 6131 9084 1273
Email: Regina.Jehle@biontech.de

Investors
ICR, Inc.
Stephanie Carrington
Phone: +1 646-277-1282
Email: Stephanie.Carrington@icrinc.com

Media
ICR, Inc.
James Heins
Phone: +1 203-682-8251
Email: James.Heins@icrinc.com

Record changed: 2020-12-27

Advertisement

More documents for BioNTech (Group)

• [1] BioNTech SE. (12/29/20). "Press Release: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of Comirnaty". New York, NY & Mainz....
• [2] BioNTech SE. (12/23/20). "Press Release: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine". New York, NY & Mainz....
• [3] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz....
• [4] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz....
• [5] BioNTech SE. (12/19/20). "Press Release: Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine". Zürich & Mainz....
• [6] BioNTech SE. (12/16/20). "Press Release: BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine". Mainz & Shanghai....
• [7] BioNTech SE. (12/12/20). "Press Release: U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older". New York, NY & Mainz....
• [8] BioNTech SE. (12/11/20). "Press Release: Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19". New York, NY & Mainz....
• [9] BioNTech SE. (11/25/20). "Press Release: BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies". Mainz & London....
• [10] BioNTech SE. (11/11/20). "Press Release: Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19". New York, NY & Mainz....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.